Tower Research Capital (TRC)’s Chembio diagnostics, Inc. CEMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,810
| Closed | -$4K | – | 6684 |
|
|
2023
Q1 | $4K | Sell |
9,810
-24
| -0.2% | -$9 | ﹤0.01% | 5161 |
|
|
2022
Q4 | $2K | Sell |
9,834
-757
| -7% | -$226 | ﹤0.01% | 5532 |
|
|
2022
Q3 | $4K | Sell |
10,591
-482
| -4% | -$329 | ﹤0.01% | 5356 |
|
|
2022
Q2 | $7K | Buy |
11,073
+3,791
| +52% | +$2.52K | ﹤0.01% | 4882 |
|
|
2022
Q1 | $6K | Buy |
+7,282
| New | +$6.79K | ﹤0.01% | 5004 |
|
|
2021
Q4 | – | Sell |
-896
| Closed | -$2K | – | 7127 |
|
|
2021
Q3 | $2K | Buy |
896
+219
| +32% | +$608 | ﹤0.01% | 5410 |
|
|
2021
Q2 | $2K | Sell |
677
-3,314
| -83% | -$11.6K | ﹤0.01% | 5159 |
|
|
2021
Q1 | $14K | Sell |
3,991
-1,669
| -29% | -$9.29K | ﹤0.01% | 4189 |
|
|
2020
Q4 | $27K | Sell |
5,660
-13,086
| -70% | -$67.6K | ﹤0.01% | 3678 |
|
|
2020
Q3 | $91K | Buy |
18,746
+16,630
| +786% | +$78.8K | ﹤0.01% | 3220 |
|
|
2020
Q2 | $7K | Buy |
2,116
+2,016
| +2,016% | +$19.1K | ﹤0.01% | 4191 |
|
|
2020
Q1 | $1K | Sell |
100
-1,671
| -94% | -$6.76K | ﹤0.01% | 2946 |
|
|
2019
Q4 | $8K | Buy |
1,771
+1,487
| +524% | +$7.25K | ﹤0.01% | 2490 |
|
|
2019
Q3 | $2K | Buy |
+284
| New | +$1.69K | ﹤0.01% | 3806 |
|
|
2019
Q2 | – | Sell |
-1,200
| Closed | -$6K | – | 4755 |
|
|
2019
Q1 | $6K | Sell |
1,200
-2,521
| -68% | -$16.4K | ﹤0.01% | 3031 |
|
|
2018
Q4 | $21K | Buy |
+3,721
| New | +$27.4K | ﹤0.01% | 1921 |
|
|
2017
Q2 | – | Sell |
-100
| Closed | -$1K | – | 4021 |
|
|
2017
Q1 | $1K | Buy |
+100
| New | +$582 | ﹤0.01% | 2950 |
|
|
2015
Q3 | – | Sell |
-551
| Closed | -$3K | – | 5614 |
|
|
2015
Q2 | $3K | Buy |
551
+431
| +359% | +$1.99K | ﹤0.01% | 3666 |
|
|
2015
Q1 | $0 | Sell |
120
-1,201
| -91% | -$4.73K | ﹤0.01% | 5563 |
|
|
2014
Q4 | $5K | Buy |
+1,321
| New | +$5.47K | ﹤0.01% | 2819 |
|
|
2014
Q3 | – | Sell |
-109
| Closed | – | – | 5458 |
|
|
2014
Q2 | $0 | Sell |
109
-591
| -84% | -$1.9K | ﹤0.01% | 5388 |
|
|
2014
Q1 | $2K | Sell |
700
-1,402
| -67% | -$4.92K | ﹤0.01% | 4061 |
|
|
2013
Q4 | $7K | Buy |
2,102
+1,702
| +426% | +$6.01K | ﹤0.01% | 3368 |
|
|
2013
Q3 | $1K | Sell |
400
-481
| -55% | -$2.04K | ﹤0.01% | 4489 |
|
|
2013
Q2 | $4K | Buy |
+881
| New | +$4.08K | ﹤0.01% | 3230 |
|
Other funds holding CEMI
Tower Research Capital (TRC)'s CEMI Position: Q2 2023 in Review
Tower Research Capital (TRC) sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 9,810 shares — an estimated $4K sold.
Tower Research Capital (TRC) first reported a position in CEMI in Q2 2013 and held it in 25 quarters. The position peaked at $91K in Q3 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.
- Tower Research Capital (TRC) reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 9,810 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $4K.
- Tower Research Capital (TRC) first reported a position in Chembio diagnostics, Inc. in Q2 2013 and held it in 25 quarters.
- Tower Research Capital (TRC)'s Chembio diagnostics, Inc. position peaked at $91K in Q3 2020.
- 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.